Physician profile
Michael J Benca
NPI 1588774061
$2,674.71
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $246 · 2021: $504 · 2022: $355 · 2023: $141 · 2024: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $535.75 | 2019-2021 | |
| Boston Scientific Corporation | $484.96 | 2019-2024 | Latitude Communicator Power Supply |
| Abbott Laboratories | $410.54 | 2019-2024 | Gallant, Aveir |
| Pfizer INC. | $253.34 | 2019-2022 | |
| Amgen INC. | $224.43 | 2019-2024 | Repatha |
| Amarin Pharma, INC. | $170.62 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $155.57 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $99.16 | 2019-2022 | |
| Intuitive Surgical, INC. | $88.58 | 2023 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $45.56 | 2021 | |
| Irhythm Technologies, INC. | $42.29 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $32.45 | 2023 | Evkeeza |
| Edwards Lifesciences Corporation | $31.88 | 2019-2023 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $20.95 | 2020 | |
| Biotronik INC. | $19.47 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.00 | 2019 | |
| Medtronic, INC. | $15.87 | 2022 | |
| Merck Sharp & Dohme LLC | $15.16 | 2021 | |
| Esperion Therapeutics, INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Benca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.